IL17A and colorectal carcinoma: It is strongly implicated in inflammatory signalling and the immune response; namely, miR-146a was identified as a major negative regulator of CRC tumorigenesis by modulating IL-17 responses and thereby limiting tumorigenic inflammation [248].